摘要
对结核分枝杆菌潜伏感染者进行预防性治疗是实现终止结核病目标关键措施之一。目前,关于不同人群预防性治疗的接受性尚不清楚。本文综述了国内外结核分枝杆菌潜伏感染预防性治疗接受性研究现状及其影响因素,以期为相关部门开展结核分枝杆菌潜伏感染预防性治疗,制定相关政策提供理论依据和参考。
Preventive treatment for latent tuberculosis infection is one of the key measures to achieve the goal of ending tuberculosis.Currently,the acceptance of preventive treatment among different populations is unclear.In this review,we summarized the status quo and influencing factors of acceptance for preventive treatment of latent tuberculosis infection at home and abroad for providing a reference to the conduction of preventive treatment of latent tuberculosis infection and policy formulation by relevant departments.
作者
袁叶敏
李士雪
周成超
YUAN Yemin;LI Shixue;ZHOU Chengchao(Centre for Health Management and Policy Research,School of Public Health,Cheeloo College of Medical,Shandong University,Ji′nan,250012;Department of Epidemiology,School of Public Health,Cheeloo College of Medicine,Shandong University,Ji′nan 250012,China;NHC Key Lab of Health Economics and Policy Research(Shandong University),Ji′nan 250012,China)
出处
《中国公共卫生》
CAS
CSCD
北大核心
2023年第7期942-947,共6页
Chinese Journal of Public Health
